Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M K, Hourfar"'
Autor:
Christof Jungbauer, Karin Stiasny, Judith H. Aberle, M. K. Hourfar, Jolanta Kolodziejek, Alexander Zoufaly, Lisa Weidner, Stephan W. Aberle, Norbert Nowotny
Publikováno v:
Eurosurveillance
Between 28 June and 17 September 2018, 27 cases of human West Nile virus infections were recorded in Austria; four cases of West Nile neuroinvasive disease, 11 cases of West Nile fever, six infections detected by blood donation screening and six impo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c264af482e25446bc6cf84caaf8d3a
https://doi.org/10.2807/1560-7917.es.2018.23.43.1800545
https://doi.org/10.2807/1560-7917.es.2018.23.43.1800545
Autor:
Stephan Göttig, Michael Schmidt, Walid Sireis, Carl P. McDonald, Volkhard A. J. Kempf, M. K. Hourfar, Erhard Seifried, Ulrich Pfeiffer
Publikováno v:
Transfusion. 55:2104-2112
BACKGROUND To increase blood safety, various procedures are currently implemented, including donor selection, optimized donor arm disinfection, and diversion. In addition, pathogen inactivation (PI) techniques can be used for platelets (PLTs) and pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fa3ba3c012c330459f322845245f61
https://doi.org/10.1111/trf.13171
https://doi.org/10.1111/trf.13171
Autor:
Michael Schmidt, Wolfgang Miesbach, M. K. Hourfar, Jörg Schüttrumpf, Erhard Seifried, S. Alesci
Publikováno v:
Transfusion Medicine and Hemotherapy. 40:32-35
Background: Xenotropic murine leukemia virus-related virus (XMRV) is a retrovirus that has recently been related to prostate cancers and chronic fatigue syndrome. Since other human-pathogenic retroviruses, such as HIV, human T-lymphotropic virus type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db2aecd301834bfd979942b8554005b
https://doi.org/10.1159/000345661
https://doi.org/10.1159/000345661
Autor:
M. K. Hourfar, Michael Schmidt, M. G. Rubin, L. B. Peris, J. Saldanha, G. T. Rodriguez, Markus Müller, E. M. López, Walid Sireis, M. I. G. Fraile, Erhard Seifried
Publikováno v:
Vox Sanguinis. 104:19-29
Background The cobas® TaqScreen MPX Test, version 2.0, a multiplex, multi-dye nucleic acid amplification technology (NAT) test from Roche was evaluated by two European Blood Banks, the German Red Cross Blood Donor Service, Frankfurt, Germany and Cen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812039786801a83051c23253128209cb
https://doi.org/10.1111/j.1423-0410.2012.01635.x
https://doi.org/10.1111/j.1423-0410.2012.01635.x
Autor:
D. Kessler, S. Ismay, S. Levicnik Stezinar, Louis M. Katz, P. Torres, A. Cheng, M. Koppelmann, P. M. Minsk, Masahiro Satake, V. Yahalom, H. Chen, P. Michel, N. Sanad, C. Taylor, Q. Park, Michael Schmidt, Ravi Reddy, A. Assal, M. Tilk, Gregory A. Foster, H. W. Reesink, S. S. Chua, C. K. Lin, Peter Flanagan, A. Eiras, Claudio Velati, A. Schuller, I. Gonzales Fraile, D. Sondag-Thull, Ewa Brojer, Margaret Fearon, R. Reimal, W. K. Roth, J. Castren, Irena Jukić, Christine Jork, M. K. Hourfar, Lisa Jarvis, Jaye P. Brodsky, M. Naukkarinen, Eilat Shinar, E. Zhiburt, V. Tefanova, C. Jennings, C. Niederhauser, Henrik Ullum, José Eduardo Levi, Marijke Weber-Schehl, Y. Xie, A. Gottreich, O Flesland, Michael P. Busch, J. O’Riordan, Volkmar Schottstedt, Susan L. Stramer, A. H. Bon, W. C. Tsoi, Lutz Pichl, D. Teo, L. Mohabir, Magdalena Łętowska, R. Offergeld, E. Castro, Bengt Ekermo, I. Sisene, Simon Panzer, Erhard Seifried, Clive R. Seed, G. Delage, Franz F. Wagner, R. Eglin, S. Wendel, Marion Vermeulen, C. Jungbauer, Christopher D. Hillyer, F. Nascimento, Sineenart Oota, L. J. Brant, Hany Kamel, Edward P. Notari, C. Politis, P. Turek
Publikováno v:
Vox Sanguinis. 102:82-90
International survey on NAT testing of blood donations : expanding implementation and yield from 1999 to 2009.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c4bf2f5d5d464aef314b86556f3f584
https://doi.org/10.1111/j.1423-0410.2011.01506.x
https://doi.org/10.1111/j.1423-0410.2011.01506.x
Autor:
Volkhard A. J. Kempf, Michael Schmidt, Erhard Seifried, K. Janetzko, G. Capalbo, Walid Sireis, M. Goebel, H-U Pfeiffer, C. Daiss, M. K. Hourfar, Brigitte Rüster
Publikováno v:
Vox Sanguinis. 101:191-199
Background The Paul-Ehrlich-Institute analysed all fatalities due to bacterial infections between 1997 and 2007. Thereafter, the platelet shelf life was reduced to a maximum of 4 days after blood donation because the majority of all cases of severe t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da12b2681031df9ec055ef9e17e463ff
https://doi.org/10.1111/j.1423-0410.2011.01485.x
https://doi.org/10.1111/j.1423-0410.2011.01485.x
Autor:
Uschi Mayr-Wohlfart, Walid Sireis, Erhard Seifried, M. K. Hourfar, Michael Schmidt, Hubert Schrezenmeier, Anna Themann
Publikováno v:
Transfusion. 51:129-136
BACKGROUND: Since 2000, blood donor screening for parvovirus B19 (B19) by nucleic acid testing (NAT) at the Ulm Institute has been conducted 6 to 8 weeks postdonation, that is, after transfusion of cellular blood products, whereas at the Frankfurt In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d2417e0baeb269ddf02c5468dc37183
https://doi.org/10.1111/j.1537-2995.2010.02780.x
https://doi.org/10.1111/j.1537-2995.2010.02780.x
Autor:
Michael Schmidt, M. K. Hourfar, Thomas Müller, Christine Jork, Franz F. Wagner, Erhard Seifried, Jürgen Bux, Volkmar Schottstedt, Lutz Pichl, J. Saldanha
Publikováno v:
Vox Sanguinis. 98:37-46
Background In 1997 the German Red Cross (GRC) blood donor services introduced mini-pool nucleic acid testing (NAT) for human immunodeficiency virus (HIV)-1, hepatitis C virus (HCV) and hepatitis B virus (HBV) to increase blood safety. With the new co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac503fe456bdee1144935e2da31a5511
https://doi.org/10.1111/j.1423-0410.2009.01219.x
https://doi.org/10.1111/j.1423-0410.2009.01219.x
Autor:
Michael Schmidt, Torsten Tonn, Hans-Peter Spengler, M. K. Hourfar, Erhard Seifried, Bernd Lambrecht
Publikováno v:
Transfusion. 49:2604-2611
Background According to German regulations and guidelines, residual red blood cells (rRBCs) and residual white blood cells (rWBCs) must number fewer than 3 x 10(9) cells/unit and 1 x 10(6) cells/unit in platelet concentrates (PCs), respectively. Due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::148d0b2acaa086c4da4f8cfdc192d2f9
https://doi.org/10.1111/j.1537-2995.2009.02326.x
https://doi.org/10.1111/j.1537-2995.2009.02326.x
Autor:
Walid Sireis, Helmut Fickenscher, Andreas Karl, Knut Gubbe, C.M. Nübling, M. K. Hourfar, H. W. Doerr, Klaus Korn, Julia Kress, Erhard Seifried, Holger F. Rabenau, B. K. Tischer, Geert Geusendam, R. Babiel, H. A. Horst, Lutz Gürtler, Michael Schmidt, Holger Hennig, Annemarie Berger, Michael Chudy
Publikováno v:
Transfusion. 49:1836-1844
BACKGROUND: In February 2007, a 63-year-old man underwent surgery. Retrospective testing with nucleic acid testing (NAT) showed that the patient was human immunodeficiency virus Type 1 (HIV-1) positive 10 days after transfusion. The transfusion-trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::598c53dfd45f1dd73d39b054b6f521a1
https://doi.org/10.1111/j.1537-2995.2009.02203.x
https://doi.org/10.1111/j.1537-2995.2009.02203.x